Extrahepatic metastases of hepatocellular carcinoma on 18F FDG PET CT
Authors:
Open Access
- 26 November 2021
- journal article
- research article
- Published by Springer Nature in Journal of the Egyptian National Cancer Institute
- Vol. 33 (1) , 1-10
Abstract
Background: To determine locations, relative frequencies, imaging features, and pattern of distribution of extrahepatic metastasis from hepatocellular carcinoma (HCC) on 2-deoxy-2-[fluorine-18]fluoro-D-glucose (18F-FDG) PET CT. Methods: FDG PET CT scans of 224 consecutive patients of HCC acquired between 2010 and 2018 were reviewed. Fifty-six patients detected with extrahepatic metastasis on FDG PET CT were retrospectively analyzed. Findings were correlated with prior/follow-up imaging studies, clinical findings, FNAC, or biopsy findings whenever available. Descriptive analysis of location, relative frequencies, imaging features, and pattern of distribution of extrahepatic metastasis was done. Results: Commonest were metastatic pulmonary nodules (55.3% patients), most of them being well-defined solid lesions (53.5%) with bilateral involvement in 44.6% patients and lower lobes of lungs along with other lobes being more frequently involved (41.0% patients). While in 7.14% patients lung nodules were FDG avid, 23.2% patients had both FDG avid and non-avid pulmonary nodules. Second most common were regional metastatic lymph nodes in 44.65% of patients seen at aortocaval (25%), paraaortic (23.21%), portocaval (21.4%), and left gastric nodal (17.8% of patients) stations. Twenty-five percent of patients had FDG avid lymph nodes and 5.36% patients had both FDG avid and FDG non-avid lymph nodes. Distant metastatic lymph nodes were third most common in 39.2% of patients seen at paratracheal (2.5%), juxtaphrenic (8.9%), and mesenteric lymphnodal (7.1%) stations. Twenty-five percent of patients had FDG avid lymph nodes while 5.36% patients had both FDG avid and FDG non-avid lymph nodes. Skeletal involvement was seen in 32.1% of patients. Commonest sites are vertebrae (16.7%), pelvis (14.2%), and ribs (10.7% patients). Six out of 7 patients had unilateral adrenal gland involvement. Bilateral adrenal gland involvement was seen in 1 patient. FDG non-avid peritoneal/omental metastases was seen in 2 patients. Brain, spleen, and muscle metastatic lesions were seen in 1 patient each out of 56 patients (1.79%). Conclusions: Lungs, regional and distant lymph nodes and skeleton are the most frequently involved sites of extrahepatic metastatic hepatocellular carcinoma. Adrenal glands, muscles, brain and peritoneum are also involved but to a lesser extent.Keywords
This publication has 23 references indexed in Scilit:
- Extrahepatic Spread of Hepatocellular Carcinoma: Spectrum of Imaging FindingsAmerican Journal of Roentgenology, 2011
- Hepatocellular carcinoma: a global viewNature Reviews Gastroenterology & Hepatology, 2010
- Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patientsLiver Transplantation, 2010
- Is There a Role for PET in the Evaluation of Subcentimeter Pulmonary Nodules?Seminars in Thoracic and Cardiovascular Surgery, 2005
- Prognostic Prediction in Patients with Hepatocellular CarcinomaSeminars in Liver Disease, 2005
- Extrahepatic Metastases of Hepatocellular CarcinomaRadiology, 2000
- Intraperitoneal Drop Metastases from Hepatocellular Carcinoma: CT and Angiographic FindingsJournal of Computer Assisted Tomography, 1996
- Intraperitoneal seeding from hepatomaAbdominal Radiology, 1994
- Prognostic factors of hepatocellular carcinoma in the west: A multivariate analysis in 206 patientsHepatology, 1990
- Primary liver cancer: Pattern of metastasisJournal of Surgical Oncology, 1987